...
首页> 外文期刊>Indian Pacing and Electrophysiology Journal >Brugada syndrome: Controversies in Risk stratification and Management
【24h】

Brugada syndrome: Controversies in Risk stratification and Management

机译:Brugada综合征:风险分层和管理方面的争议

获取原文
           

摘要

In the 18 years since the first description of Brugada Syndrome in a small series of cardiac arrest survivors it has become evident that there is a marked spectrum in phenotype and prognosis. An internal cardiac defibrillator (ICD) is the only established therapy but is associated with significant morbidity. A number of registries have published their data, but risk stratification, particularly in asymptomatic patients, remains controversial. This article summarises the evidence to enable the clinician to make informed management decisions on an individual basis.
机译:自从在一小部分心脏骤停幸存者中首次描述Brugada综合征以来的18年中,很明显,在表型和预后方面存在着明显的变化。内置式心脏除纤颤器(ICD)是唯一已确立的疗法,但其发病率很高。许多注册管理机构已经发布了他们的数据,但是风险分层,尤其是对无症状患者的风险分层仍然存在争议。本文总结了使临床医生能够根据个人情况做出明智的管理决策的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号